ANI Pharmaceuticals, Inc. recently reported fourth-quarter 2025 results, with sales rising to US$247.06 million and net income reaching US$27.49 million, a sharp turnaround from a net loss a year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results